Depressive disorder
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, the behavioral indicators of depression showed strong correlations with the serum levels and the hippocampal content of NPY.
|
28582442 |
2017 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
BEFREE |
Both NPY and CGRP were higher in PD patients with comorbid depression compared to MDD patients.
|
28659833 |
2017 |
Alzheimer's Disease
|
0.600 |
Biomarker
|
disease |
BEFREE |
Overall, increased delivery of NPY to the CNS for AD might be an effective therapy especially if combined with an anti-Aβ therapeutic.
|
26620558 |
2016 |
Alzheimer's Disease
|
0.600 |
Biomarker
|
disease |
BEFREE |
Numbers of neuropeptide Y (NPY) and parvalbumin (PV) immunoreactive (IR) cells were decreased in the hippocampus of 1 month-old TgCRND8 mouse AD model in a sub-regionally specific manner.
|
28154533 |
2016 |
Mental Depression
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Among all candidate substrates, DPP4 displays highest affinity for NPY, an endogenous anxiolytic neurotransmitter that is suggested as a candidate biomarker in post-traumatic stress disorder (PTSD) and depression.
|
25635612 |
2015 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Among all candidate substrates, DPP4 displays highest affinity for NPY, an endogenous anxiolytic neurotransmitter that is suggested as a candidate biomarker in post-traumatic stress disorder (PTSD) and depression.
|
25635612 |
2015 |
Alzheimer's Disease
|
0.600 |
Biomarker
|
disease |
BEFREE |
Finally, we recapitulate our recent in-vitro evidence for the involvement of neurotrophin nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in the neuroprotective effect elicited by NPY in AD neuron-like models (neuroblastoma cells or primary cultures exposed to toxic concentrations of Aβ's pathogenic fragment 25-35), and propose a putative mechanism based on NPY-induced inhibition of voltage-dependent Ca(2+) influx in pre- and post-synaptic neurons.
|
25026432 |
2014 |
Mental Depression
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Using a recombinant adeno-associated viral (rAAV) vector, we addressed this idea by testing effects on anxiolytic- and depression-like behaviours in adult mice after overexpression of NPY transgene in the amygdala and/or hippocampus, two brain regions implicated in emotional behaviours.
|
25267070 |
2014 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Using a recombinant adeno-associated viral (rAAV) vector, we addressed this idea by testing effects on anxiolytic- and depression-like behaviours in adult mice after overexpression of NPY transgene in the amygdala and/or hippocampus, two brain regions implicated in emotional behaviours.
|
25267070 |
2014 |
Alcoholic Intoxication, Chronic
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Association of the NPY gene with alcohol dependence was tested by using logistic regression and haplotype analyses and linkage disequilibrium.
|
23652361 |
2013 |
Alcoholic Intoxication, Chronic
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Association of the NPY gene with alcohol dependence was tested by using logistic regression and haplotype analyses and linkage disequilibrium.
|
23652361 |
2013 |
Mental Depression
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Statistical analysis showed a significant correlation between the SNP sites rs16139 in NPY and the morbidity of depression.
|
23468908 |
2013 |
Mental Depression
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
However, alterations in anxiety- and depression-regulating genes were present in the hypothalamus of BACHD mice including reduced mRNA expression of neuropeptide Y, tachykinin receptor 3 and vesicular monoamine transporter type 2 as well as increased expression of cocaine and amphetamine regulated transcript.
|
23697793 |
2013 |
Mental Depression
|
0.600 |
Biomarker
|
disease |
BEFREE |
NPY has recently gained much attention as an endogenous antiepileptic and antidepressant agent, as drugs with antiepileptic and/or mood-stabilizing properties may exert their action by increasing NPY concentrations, which in turn can reduce anxiety and depression levels, dampen seizures or increase seizure threshold.
|
23994577 |
2013 |
Mental Depression
|
0.600 |
Biomarker
|
disease |
PSYGENET |
However, alterations in anxiety- and depression-regulating genes were present in the hypothalamus of BACHD mice including reduced mRNA expression of neuropeptide Y, tachykinin receptor 3 and vesicular monoamine transporter type 2 as well as increased expression of cocaine and amphetamine regulated transcript.
|
23697793 |
2013 |
Mental Depression
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Statistical analysis showed a significant correlation between the SNP sites rs16139 in NPY and the morbidity of depression.
|
23468908 |
2013 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
BEFREE |
NPY has recently gained much attention as an endogenous antiepileptic and antidepressant agent, as drugs with antiepileptic and/or mood-stabilizing properties may exert their action by increasing NPY concentrations, which in turn can reduce anxiety and depression levels, dampen seizures or increase seizure threshold.
|
23994577 |
2013 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
However, alterations in anxiety- and depression-regulating genes were present in the hypothalamus of BACHD mice including reduced mRNA expression of neuropeptide Y, tachykinin receptor 3 and vesicular monoamine transporter type 2 as well as increased expression of cocaine and amphetamine regulated transcript.
|
23697793 |
2013 |
Depressive disorder
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Statistical analysis showed a significant correlation between the SNP sites rs16139 in NPY and the morbidity of depression.
|
23468908 |
2013 |
Depressive disorder
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
However, alterations in anxiety- and depression-regulating genes were present in the hypothalamus of BACHD mice including reduced mRNA expression of neuropeptide Y, tachykinin receptor 3 and vesicular monoamine transporter type 2 as well as increased expression of cocaine and amphetamine regulated transcript.
|
23697793 |
2013 |
Depressive disorder
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Statistical analysis showed a significant correlation between the SNP sites rs16139 in NPY and the morbidity of depression.
|
23468908 |
2013 |
Alcoholic Intoxication, Chronic
|
0.600 |
Biomarker
|
disease |
PSYGENET |
Neuropeptide Y (NPY) in the extended amygdala is recruited during the transition to alcohol dependence.
|
22938859 |
2012 |
Alcoholic Intoxication, Chronic
|
0.600 |
Biomarker
|
disease |
BEFREE |
Neuropeptide Y (NPY) in the extended amygdala is recruited during the transition to alcohol dependence.
|
22938859 |
2012 |
Alzheimer's Disease
|
0.600 |
Therapeutic
|
disease |
RGD |
We suggest that NPY, perhaps acting via NPY Y1 receptors, might interact with the endogenous cholinergic system and play a role in improving the learning and memory processes in the rats with AD-like condition.
|
22266216 |
2012 |
Mental Depression
|
0.600 |
Biomarker
|
disease |
PSYGENET |
No significant differences in NPY IgG autoAb affinities between patients with depression and controls were found, but higher affinity of IgG autoAbs for NPY was associated with lower body mass index and prevented NPY-induced orexigenic response in mice after their central injection.
|
22365482 |
2012 |